Concepedia

Catherine Gillotin

CG

Statistics

Publications

22

Citations

768

H-Index

17

Active since

1991

Affiliations

Hôpital Bichat-Claude-Bernard(Current)

Wellcome Library

Research Triangle Park Foundation

Sorbonne Université

Université Claude Bernard Lyon 1

Catherine Gillotin is an author at Hôpital Bichat-Claude-Bernard specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1991–2002

22

Publications

22

Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral Dosing

Brian M. Sadler, Catherine Gillotin, Yu Lou et al. · Antimicrobial Agents and Chemotherapy · 2001 · 98 citations · Full text

, , +15

Single-Dose Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor, in Subjects with Normal or Impaired Hepatic Function

L. Veronese, Jacques Rautaureau, Brian M. Sadler et al. · Antimicrobial Agents and Chemotherapy · 2000 · 77 citations

, , +17

In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum.

LK Basco, Catherine Gillotin, F. Giménez et al. · British Journal of Clinical Pharmacology · 1992 · 72 citations · Full text

, , +15

Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food

Gregory E. Chittick, Catherine Gillotin, James A. McDowell et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1999 · 58 citations

, , +17

Pharmacokinetic Interaction between Amprenavir and Clarithromycin in Healthy Male Volunteers

Donald F. Brophy, Debra S. Israel, Antonio Pastor et al. · Antimicrobial Agents and Chemotherapy · 2000 · 48 citations

, , +8

1–5 of 22